NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
12 hedge funds and large institutions have $1.79M invested in NeuBase Therapeutics, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and closing their positions.
Holders
12
Holders Change
+5
Holders Change %
+71.43%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
FNBT
1
FineMark National Bank & Trust
Fort Myers,
Florida
|
$97K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Goldman Sachs
New York
| $1.21M | 148,693 | +148,693 | New |
|
2
Geode Capital Management
Boston,
Massachusetts
| $151K | 18,623 | +18,623 | New |
|
|
FNBT
3
FineMark National Bank & Trust
Fort Myers,
Florida
| $97K | 11,935 | -3,732 | -24% |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $97K | 11,900 | +11,900 | New |
|
5
State Street
Boston,
Massachusetts
| $92K | 11,300 | +11,300 | New |
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $87K | 10,771 | +10,771 | New |
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $24K | 3,000 | +1,500 | +100% |
|
|
U
8
UBS
Zurich,
Switzerland
| $15K | 1,893 | +322 | +20% |
|
9
First Manhattan
New York
| $13K | 1,667 | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $7K | 900 | +448 | +99% |
|
11
Wells Fargo
San Francisco,
California
| $3K | 334 | – | – |
|
|
EWM
12
Edge Wealth Management
New York
| $0 | 1 | – | – |
|